These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26057137)

  • 1. Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations.
    Eidem S; Tete SM; Jul-Larsen Å; Hoschler K; Montomoli E; Brokstad KA; Cox RJ
    Vaccine; 2015 Aug; 33(33):4146-54. PubMed ID: 26057137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and safety of a China-made monovalent pandemic (H1N1) 2009 influenza A vaccine in healthcare workers in Guangzhou, China.
    Zhan Y; Yang Z; Li L; Ye D; Wu H; Fu R; Zhao S; Wang Y; Zhou R; Chen R
    Jpn J Infect Dis; 2011; 64(3):190-4. PubMed ID: 21617301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody Responses to Influenza A/H1N1pdm09 Virus After Pandemic and Seasonal Influenza Vaccination in Healthcare Workers: A 5-Year Follow-up Study.
    Trieu MC; Jul-Larsen Å; Sævik M; Madsen A; Nøstbakken JK; Zhou F; Skrede S; Cox RJ
    Clin Infect Dis; 2019 Jan; 68(3):382-392. PubMed ID: 29893797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
    Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects.
    Hatz C; von Sonnenburg F; Casula D; Lattanzi M; Leroux-Roels G
    Vaccine; 2012 May; 30(23):3470-7. PubMed ID: 22446638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of prior infection and repeated vaccination on post-vaccination antibody titers of the influenza A(H1N1)pdm09 strain in Taiwan schoolchildren: Implications for public health.
    Liu W; Lien YH; Lee PI; Chan TC; Wang LC; Yang CR; Ho MS; Chen JR; Ku CC; King CC
    Vaccine; 2022 May; 40(24):3402-3411. PubMed ID: 35525727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza A(H1N1)pdm09 antibodies after pandemic and trivalent seasonal influenza vaccination as well as natural infection in November 2010 in Hamburg, Germany.
    Cramer J; Mac T; Hogan B; Stauga S; Eberhardt S; Wichmann O; Mertens T; Burchard G
    Euro Surveill; 2012 Jan; 17(2):. PubMed ID: 22264864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains.
    Luytjes W; Enouf V; Schipper M; Gijzen K; Liu WM; van der Lubben M; Meijer A; van der Werf S; Soethout EC
    Vaccine; 2012 Jul; 30(35):5262-9. PubMed ID: 22691431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
    Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V
    HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term immunogenicity of the pandemic influenza A/H1N1 2009 vaccine among health care workers: influence of prior seasonal influenza vaccination.
    Song JY; Cheong HJ; Seo YB; Kim IS; Noh JY; Choi WS; Lee J; Jeong HW; Kee SY; Kim WJ
    Clin Vaccine Immunol; 2013 Apr; 20(4):513-6. PubMed ID: 23365206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects.
    Liu W; Ma MJ; Tang F; He C; Zhang XA; Jiang LF; Xin DS; Hu CY; Looman C; Cao WC
    Vaccine; 2012 Jul; 30(32):4785-9. PubMed ID: 22633868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response to 2009 pandemic H1N1 influenza virus A monovalent vaccine in children with cancer.
    Yen TY; Jou ST; Yang YL; Chang HH; Lu MY; Lin DT; Lin KH; Huang LM; Chang LY
    Pediatr Blood Cancer; 2011 Dec; 57(7):1154-8. PubMed ID: 21425448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination.
    de Bruijn IA; Remarque EJ; Jol-van der Zijde CM; van Tol MJ; Westendorp RG; Knook DL
    J Infect Dis; 1999 Jan; 179(1):31-6. PubMed ID: 9841819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
    Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
    Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Debate on annual influenza vaccination in healthcare workers for the same subtype under the vaccine shortage.
    Song JY; Ha SH; Kee SY; Jeong HW; Cheong HJ; Kim WJ
    J Clin Virol; 2007 Feb; 38(2):149-52. PubMed ID: 17196876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination.
    Lagler H; Wenisch JM; Tobudic S; Gualdoni GA; Rödler S; Rasoul-Rockenschaub S; Jaksch P; Redlberger-Fritz M; Popow-Kraupp T; Burgmann H
    Vaccine; 2011 Sep; 29(40):6888-93. PubMed ID: 21803100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a 2009 pandemic influenza virus A H1N1 vaccine, administered simultaneously with the seasonal influenza vaccine, in children receiving chemotherapy.
    Ottóffy G; Horváth P; Muth L; Sólyom A; Garami M; Kovács G; Nyári T; Molnár D; Pauler G; Jankovics I
    Pediatr Blood Cancer; 2014 Jun; 61(6):1013-6. PubMed ID: 24395342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.
    Chang YT; Guo CY; Tsai MS; Cheng YY; Lin MT; Chen CH; Shen D; Wang JR; Sung JM
    Vaccine; 2012 Jul; 30(33):5009-18. PubMed ID: 22658967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immune response to influenza A(H1N1)pdm2009 in patients with natural infection and in vaccine recipients in the 2009 pandemic.
    Kumagai T; Nakayama T; Okuno Y; Kase T; Nishimura N; Ozaki T; Miyata A; Suzuki E; Okafuji T; Okafuji T; Ochiai H; Nagata N; Tsutsumi H; Okamatsu M; Sakoda Y; Kida H; Ihara T
    Viral Immunol; 2014 Oct; 27(8):368-74. PubMed ID: 25211638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.